FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne

Article Link: FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne

FORT WORTH, Texas – (October 4, 2019) – Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced today that the U.S. Food and Drug Administration (FDA) approved Aklief (trifarotene) Cream,…

Source: FDA New Drug Approvals